During the season of monsoon, cases of dengue increase and the peak of cases is achieved during the middle of August to November. The patient suffered from a dengue condition that worsened when there sudden fall in platelets. The condition worsens when the body is unable to produce enough platelets to recover. Problems arise when platelets need to be injected externally, which increases treatment cost, and sometimes the patient cannot recover and collapses. This new generation vaccine approval will improve the dengue cases in india lets see how it will work in India.
QDENGA Dengue Vaccine: India's First FDA-Approved Dengue Vaccine, also known as TAK-003, developed by Takeda.
Benefits:
This vaccine offers protection against all four types of Dengue serotypes. Once the vaccine is administered to the patient effect of the vaccine persists for 4 years. There is a strong reduction in symptomatic dengue(Laboratories induced infection).
Dosage :
It is administered as two doses three months apart, and unlike Dengvaxia, it does not require prior dengue infection or pre-vaccination serological testing.
Eligibility :
QDENGA recently became the first dengue vaccine approved in India for individuals aged 4–60 years. It does not require prior dengue infection or pre-vaccination serological testing.
FAQ:
1. What is the QDENGA vaccine?
QDENGA is a tetravalent dengue vaccine developed by Takeda.
2. What is the QDENGA vaccine used for?
QDENGA is used to help prevent dengue fever and reduce the risk of severe dengue.
3. How many doses of QDENGA are required?
The complete vaccination schedule consists of 2 doses, administered 3 months apart.
4. Who can receive the QDENGA vaccine?
QDENGA has been approved for individuals 4 to 60 years of age. Always consult a healthcare professional before vaccination.
5. Does QDENGA protect against all four dengue virus types?
Yes. QDENGA is designed to protect against all four dengue virus serotypes (DENV-1, DENV-2, DENV-3, and DENV-4).
6. Is a blood test required before receiving QDENGA?
No. Unlike some earlier dengue vaccines, QDENGA does not require pre-vaccination testing for previous dengue infection.
7. Can QDENGA prevent severe dengue?
Yes, QDENGA helps reduce the risk of severe dengue and dengue-related hospitalisation.
8. Can I still get dengue after vaccination?
Yes, it does not guarantee 100% protection. Mosquito bite prevention remains important.
9. Is QDENGA safe?
Yes, QDENGA has been evaluated in large clinical trials and approved by the Indian Government(FDA).
10. Who should not receive QDENGA?
QDENGA is generally not recommended for patients with allergic conditions or weak immunity, or Pregnant or breastfeeding women.
11. Can someone who has already had dengue receive QDENGA?
Yes.
12. How effective is QDENGA?
Clinical studies have demonstrated that QDENGA significantly reduces the risk of symptomatic dengue.
13. What are the common side effects of QDENGA?
- Pain or redness at the injection site
- Headache
- Fatigue
- Muscle pain
- Mild fever
These reactions are usually mild and temporary.
14. Can QDENGA replace mosquito control measures?
No.
15. Where can I get the QDENGA vaccine?
QDENGA is available through authorised hospitals, vaccination centres, and healthcare providers in countries where it has been approved. Availability may vary by region.
Reviewed By: Vinita Kaushik, D.Pharma, MBA & Sandeep Khandelwal B.tech(Biotechnology) 11 years In Pharmaceutical Industry
